Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lex Wunderink

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
BMC Psychiatry|March 31, 2019
Searching for the optimal number of response alternatives for the distress scale of the four-dimensional symptom questionnaireJan van Bebber, Johanna T W Wigman, Rob R Meijer, et al.
BMC Psychiatry|September 5, 2018
Self-monitoring and personalized feedback based on the experiencing sampling method as a tool to boost depression treatment: a protocol of a pragmatic randomized controlled trial (ZELF-i)Jojanneke A Bastiaansen, Maaike Meurs, Renee Stelwagen, et al.
NPJ Schizophrenia|June 24, 2016
Lower prefrontal activation during emotion regulation in subjects at ultrahigh risk for psychosis: an fMRI-studyJorien van der Velde, Esther M Opmeer, Edith J Liemburg, et al.
BMJ Open|January 24, 2018
Study protocol for a prospective cohort study examining the predictive potential of dynamic symptom networks for the onset and progression of psychosis: the Mapping Individual Routes of Risk and Resilience (Mirorr) studySanne H Booij, Marieke Wichers, Peter de Jonge, et al.
International Journal of Methods in Psychiatric Research|September 25, 2018
Application of the Patient-Reported Outcomes Measurement Information System (PROMIS) item parameters for Anxiety and Depression in the NetherlandsJan van Bebber, Gerard Flens, Johanna T W Wigman, et al.
Schizophrenia Research|May 14, 2019
Course and predictors of symptomatic remission in late-life schizophrenia: A 5-year follow-up study in a Dutch psychiatric catchment areaSjors M M Lange, Paul D Meesters, Max L Stek, et al.
Schizophrenia Research|August 15, 2009
Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory-verbal hallucinations in schizophrenia: a randomized controlled trialAns Vercammen, Henderikus Knegtering, Richard Bruggeman, et al.
Psychiatry Research|December 3, 2010
Neurocognition and recovery in first episode psychosisGunnar Faber, Henderikus G O M Smid, Arthur R Van Gool, et al.
The Journal of Clinical Psychiatry|March 8, 2012
Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trialGunnar Faber, Henderikus G O M Smid, Arthur R Van Gool, et al.
Psychiatry Research|February 26, 2013
Depression and social anxiety in help-seeking patients with an ultra-high risk for developing psychosisJudith Rietdijk, Helga K Ising, Sara Dragt, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
BMC Psychiatry|March 31, 2019
Searching for the optimal number of response alternatives for the distress scale of the four-dimensional symptom questionnaireJan van Bebber, Johanna T W Wigman, Rob R Meijer, et al.
BMC Psychiatry|September 5, 2018
Self-monitoring and personalized feedback based on the experiencing sampling method as a tool to boost depression treatment: a protocol of a pragmatic randomized controlled trial (ZELF-i)Jojanneke A Bastiaansen, Maaike Meurs, Renee Stelwagen, et al.
NPJ Schizophrenia|June 24, 2016
Lower prefrontal activation during emotion regulation in subjects at ultrahigh risk for psychosis: an fMRI-studyJorien van der Velde, Esther M Opmeer, Edith J Liemburg, et al.
BMJ Open|January 24, 2018
Study protocol for a prospective cohort study examining the predictive potential of dynamic symptom networks for the onset and progression of psychosis: the Mapping Individual Routes of Risk and Resilience (Mirorr) studySanne H Booij, Marieke Wichers, Peter de Jonge, et al.
International Journal of Methods in Psychiatric Research|September 25, 2018
Application of the Patient-Reported Outcomes Measurement Information System (PROMIS) item parameters for Anxiety and Depression in the NetherlandsJan van Bebber, Gerard Flens, Johanna T W Wigman, et al.
Schizophrenia Research|May 14, 2019
Course and predictors of symptomatic remission in late-life schizophrenia: A 5-year follow-up study in a Dutch psychiatric catchment areaSjors M M Lange, Paul D Meesters, Max L Stek, et al.
Schizophrenia Research|August 15, 2009
Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory-verbal hallucinations in schizophrenia: a randomized controlled trialAns Vercammen, Henderikus Knegtering, Richard Bruggeman, et al.
Psychiatry Research|December 3, 2010
Neurocognition and recovery in first episode psychosisGunnar Faber, Henderikus G O M Smid, Arthur R Van Gool, et al.
The Journal of Clinical Psychiatry|March 8, 2012
Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trialGunnar Faber, Henderikus G O M Smid, Arthur R Van Gool, et al.
Psychiatry Research|February 26, 2013
Depression and social anxiety in help-seeking patients with an ultra-high risk for developing psychosisJudith Rietdijk, Helga K Ising, Sara Dragt, et al.
Pageof 6